Vivos Therapeutics

VVOS · NASDAQ

$0.1406+$0.0057 (+4.23%)TodayMarket closed ·
Prev close $0.1349

About VVOS

Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). The company is headquartered in Littleton, Colorado and currently employs 268 full-time employees. The company went IPO on 2020-12-11. The firm's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The firm's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The firm has sleep testing centers and associated medical sleep practice.

Employees
270
Headquarters
Littleton, Colorado
Listed
Dec 11, 2020
Sector
Health Care
Industry
Health Care Providers & Services
Website
vivos.com

Leadership

Vivos Therapeutics executives
NameTitleSince
R. Kirk Huntsman—2016
Bradford Amman——
Ralph Green——
Gregg Johnson——
Anja Krammer——
Mark Lindsay——
Leonard Sokolow——
Matthew Thompson——

Revenue by product and region

Fiscal year ended Dec 31, 2025: $17.44M total revenue

By product

  • Service [Member]$10.96M62.8%
  • Product [Member]$6.49M37.2%

Similar companies

Companies in the same industry as Vivos Therapeutics

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.